Neurocritical Care

, Volume 19, Issue 3, pp 293–298 | Cite as

Infarct Volume Predicts Delayed Recovery in Patients with Subarachnoid Hemorrhage and Severe Neurological Deficits

  • Neil F. Rosenberg
  • Storm M. Liebling
  • Adam R. Kosteva
  • Matthew B. Maas
  • Shyam Prabhakaran
  • Andrew M. Naidech



Recovery is common after subarachnoid hemorrhage (SAH), even in patients who are severely disabled at hospital discharge. Little is known about predictors of late recovery in such patients, even though such knowledge may influence treatment decisions. We hypothesized that cerebral infarction volume would be associated with 3 months outcomes in patients who are severely disabled at 14 days.


We prospectively identified consecutive aneurysmal SAH patients, documented the development of cerebral infarction, and ascertained the modified Rankin Scale (mRS) at 14 days and 3 months. We included patients with mRS 4 or 5 and NIH Stroke Scale (NIHSS) at least 8 on hospital day 14 (i.e., severe neurologic impairment) and calculated infarct volume in a semi-automated fashion using CT imaging. We explored outcome determinants with ordinal regression.


At 14 days, 66 patients were severely disabled, 65 (98.5 %) of whom had mRS of 5; the median NIHSS was 21 [14–24]. At 3 months, 20 (32.8 %) of the 61 patients with known outcomes were independent. Larger infarction volumes were associated with death (20.4 vs. 0.85 mL, P = 0.02). In ordinal regression, increased infarct volume was associated with the worse mRS after correction for WFNS grade, age, and withdrawal of life support (OR 1.01 per mL of infarct, 95 % CI 1.01–1.03, P = 0.01).


After SAH, even with severe neurological injury at 14 days, good recovery is frequent and is associated with lower infarction volume. These data may help clinicians inform surrogate decision makers as they plan the future care of such severely disabled patients.


Subarachnoid hemorrhage Prognosis Cerebral infarction 



This work was departmentally funded. The infrastructure for automated data retrieval was funded in part by National Institutes of Health through a Grant to Northwestern University’s Clinical and Translational Sciences (NUCATS) UL1RR025741. Dr. Rosenberg received support from the Goldberg Charitable Trust of Northwestern Memorial Hospital to present these data in abstract form at the American Academy of Neurology Annual Meeting.


  1. 1.
    Nieuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rinkel GJ. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol. 2009;8:635–42.PubMedCrossRefGoogle Scholar
  2. 2.
    Lovelock CE, Rinkel GJ, Rothwell PM. Time trends in outcome of subarachnoid hemorrhage. Population-based study and systematic review. Neurology. 2010;74:1494–501.PubMedCrossRefGoogle Scholar
  3. 3.
    Harrison N, Wilson FC. Independent living following a ‘Do Not Resuscitate’ order after subarachnoid haemorrhage. Disabil Rehabil. 2007;29:347–52.PubMedCrossRefGoogle Scholar
  4. 4.
    Greebe P, Rinkel GJ, Algra A. Long-term outcome of patients discharged to a nursing home after aneurysmal subarachnoid hemorrhage. Arch Phys Med Rehabil. 2010;91:247–51.PubMedCrossRefGoogle Scholar
  5. 5.
    Lloyd CB, Nietert PJ, Silvestri GA. Intensive care decision making in the seriously ill and elderly. Crit Care Med. 2004;32:649–54.PubMedCrossRefGoogle Scholar
  6. 6.
    Vergouwen MD, Ilodigwe D, Macdonald RL. Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects. Stroke. 2011;42:924–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Vergouwen MD, Etminan N, Ilodigwe D, Macdonald RL. Lower incidence of cerebral infarction correlates with improved functional outcome after aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2011;31:1545–53.PubMedCrossRefGoogle Scholar
  8. 8.
    Naidech AM, Bendok BR, Bassin SL, Bernstein RA, Batjer HH, Bleck TP. Classification of cerebral infarction after subarachnoid hemorrhage impacts outcome. Neurosurgery. 2009;64:1052–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Schmidt JM, Wartenberg KE, Fernandez A, et al. Frequency and clinical impact of asymptomatic cerebral infarction due to vasospasm after subarachnoid hemorrhage. J Neurosurg. 2008;109:1052–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Vora NA, Shook SJ, Schumacher HC, et al. A 5-item scale to predict stroke outcome after cortical middle cerebral artery territory infarction: validation from results of the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) Study. Stroke. 2011;42:645–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Anonymous Report of World Federation of Neurological Surgeons Committee on a Universal Subarachnoid Hemorrhage Grading Scale. J Neurosurg 1988;68:985–986.Google Scholar
  12. 12.
    Brott T, Adams HP Jr, Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20:864–70.PubMedCrossRefGoogle Scholar
  13. 13.
    Claassen J, Bernardini GL, Kreiter K, et al. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the fisher scale revisited. Stroke. 2001;32:2012–20.PubMedCrossRefGoogle Scholar
  14. 14.
    Banks JL, Marotta CA. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke. 2007;38:1091–6.PubMedCrossRefGoogle Scholar
  15. 15.
    Saver JL, Filip B, Hamilton S, et al. Improving the reliability of stroke disability grading in clinical trials and clinical practice: the Rankin Focused Assessment (RFA). Stroke. 2010;41:992–5.PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Anonymous Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333:1581–7.CrossRefGoogle Scholar
  17. 17.
    Briggs DE, Felberg RA, Malkoff MD, Bratina P, Grotta JC. Should mild or moderate stroke patients be admitted to an intensive care unit? Stroke. 2001;32:871–6.PubMedCrossRefGoogle Scholar
  18. 18.
    Tseng MY, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke. 2005;36:1627–32.PubMedCrossRefGoogle Scholar
  19. 19.
    Sen J, Belli A, Albon H, Morgan L, Petzold A, Kitchen N. Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage. Lancet Neurol. 2003;2:614–21.PubMedCrossRefGoogle Scholar
  20. 20.
    Vergouwen MD, Vermeulen M, van Gijn J, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke. 2010;41:2391–5.PubMedCrossRefGoogle Scholar
  21. 21.
    Diringer MN, Bleck TP, Claude Hemphill J, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15:211–40.PubMedCrossRefGoogle Scholar
  22. 22.
    Naidech AM, Jovanovic B, Liebling S, et al. Reduced platelet activity is associated with early clot growth and worse 3 months outcome after intracerebral hemorrhage. Stroke. 2009;40:2398–401.PubMedCrossRefGoogle Scholar
  23. 23.
    Naidech AM, Rosenberg NF, Maas MB, Bendok BR, Batjer HH, Nemeth AJ. Predictors of hemorrhage volume and disability after perimesencephalic subarachnoid hemorrhage. Neurology. 2012;78:811–5.PubMedCrossRefGoogle Scholar
  24. 24.
    The Optimising Analysis of Stroke Trials (OAST) Collaboration. Can we improve the statistical analysis of stroke trials? Statistical reanalysis of functional outcomes in stroke trials. Stroke. 2007;38:1911–5.CrossRefGoogle Scholar
  25. 25.
    Bath PM, Geeganage C, Gray LJ, Collier T, Pocock S. Use of ordinal outcomes in vascular prevention trials: comparison with binary outcomes in published trials. Stroke. 2008;39:2817–23.PubMedCrossRefGoogle Scholar
  26. 26.
    Connolly ES, Rabinstein AA, Carhuapoma JR, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012;43:1711–37.PubMedCrossRefGoogle Scholar
  27. 27.
    Hanel RA, Xavier AR, Mohammad Y, Kirmani JF, Yahia AM, Qureshi AI. Outcome following intracerebral hemorrhage and subarachnoid hemorrhage. Neurol Res. 2002;24(1):58–62.CrossRefGoogle Scholar
  28. 28.
    Wartenberg KE, Schmidt JM, Claassen J, et al. Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med. 2006;34:617–23.PubMedGoogle Scholar
  29. 29.
    Minne L, Abu-Hanna A, de Jonge E. Evaluation of SOFA-based models for predicting mortality in the ICU: a systematic review. Crit Care. 2008;12:R161.PubMedCrossRefGoogle Scholar
  30. 30.
    Rabinstein AA, Friedman JA, Weigand SD, et al. Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke. 2004;35:1862–6.PubMedCrossRefGoogle Scholar
  31. 31.
    van den Berg R, Foumani M, Schröder RD, et al. Predictors of outcome in World Federation of Neurologic Surgeons grade V aneurysmal subarachnoid hemorrhage patients. Crit Care Med. 2011;39:2722–7.PubMedGoogle Scholar
  32. 32.
    Kramer AH, Hehir M, Nathan B, et al. A comparison of 3 radiographic scales for the prediction of delayed ischemia and prognosis following subarachnoid hemorrhage. J Neurosurg. 2008;109:199–207.PubMedCrossRefGoogle Scholar
  33. 33.
    Becker KJ, Baxter AB, Cohen WA, et al. Withdrawal of support in intracerebral hemorrhage may lead to self-fulfilling prophecies. Neurology. 2001;56:766–72.PubMedCrossRefGoogle Scholar
  34. 34.
    Naidech AM, Bernstein RA, Bassin SL, et al. How patients die after intracerebral hemorrhage. Neurocrit Care. 2009;11:45–9.PubMedCrossRefGoogle Scholar
  35. 35.
    Schwarze ML, Bradley CT, Brasel KJ. Surgical”buy-i”: the contractual relationship between surgeons and patients that influences decisions regarding life-supporting therapy. Crit Care Med. 2010;38:843–8.PubMedCentralPubMedCrossRefGoogle Scholar
  36. 36.
    Ovbiagele B, Saver JL. Day-90 acute ischemic stroke outcomes can be derived from early functional activity level. Cerebrovasc Dis. 2010;29:50–6.PubMedCrossRefGoogle Scholar
  37. 37.
    Wartenberg KE, Sheth SJ, Michael Schmidt J, et al. Acute ischemic injury on diffusion-weighted magnetic resonance imaging after poor grade subarachnoid hemorrhage. Neurocrit Care. 2011;14:407–15.PubMedCrossRefGoogle Scholar
  38. 38.
    Weidauer S, Lanfermann H, Raabe A, Zanella F, Seifert V, Beck J. Impairment of cerebral perfusion and infarct patterns attributable to vasospasm after aneurysmal subarachnoid hemorrhage: a prospective MRI and DSA study. Stroke. 2007;38:1831–6.PubMedCrossRefGoogle Scholar
  39. 39.
    Shimoda M, Takeuchi M, Tominaga J, Oda S, Kumasaka A, Tsugane R. Asymptomatic versus symptomatic infarcts from vasospasm in patients with subarachnoid hemorrhage: serial magnetic resonance imaging. Neurosurgery. 2001;49:1341–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Neil F. Rosenberg
    • 1
  • Storm M. Liebling
    • 1
  • Adam R. Kosteva
    • 1
  • Matthew B. Maas
    • 1
    • 2
  • Shyam Prabhakaran
    • 1
  • Andrew M. Naidech
    • 1
    • 2
    • 3
  1. 1.Section on Neurocritical Care, Ken & Ruth Davee Department of NeurologyNorthwestern University Feinberg School of MedicineChicagoUSA
  2. 2.Department of AnesthesiologyNorthwestern University Feinberg School of MedicineChicagoUSA
  3. 3.Department of Neurological SurgeryNorthwestern University Feinberg School of MedicineChicagoUSA

Personalised recommendations